Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100B | P04271 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.41 |
| ▸ | RXRA | P19793 | 4/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14922242 | 0.85 | ADRB1 (0.47) | ALDH1A1MAPTHTTCYP1A2CYP2C19 | |
| SCHEMBL14922288 | 0.85 | KDM4E (0.49) | ALDH1A1MAPTMEN1GAAMAPK1 | |
| SCHEMBL17543322 | 0.82 | MCHR1 (0.40) | MCHR1RXRAGRIN1GRIN2BCHRM2 | |
| SCHEMBL14922296 | 0.76 | HTR3A (0.47) | ALDH1A1MAPTMEN1LMNAGAA | |
| SCHEMBL14922247 | 0.76 | ADRB1 (0.49) | ALDH1A1MAPTHTTCYP1A2CYP2C19 | |
| SCHEMBL2249128 | 0.75 | MAPT (0.46) | ALDH1A1MAPTLMNAMCHR1CHRM2 | |
| SCHEMBL5276757 | 0.75 | MAPT (0.46) | ALDH1A1MAPTLMNAMCHR1CHRM2 | |
| SCHEMBL11118270 | 0.74 | CYP17A1 (0.46) | ALDH1A1MEN1LMNAGAAPKM | |
| SCHEMBL2536408 | 0.72 | ACACB (0.42) | MCHR1RXRAGRIN1GRIN2BCHRM2 | |
| SCHEMBL15940187 | 0.71 | CYP17A1 (0.49) | MCHR1RXRAGRIN1GRIN2BCYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | ENODIA THERAPEUTICS SAS (FR) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | SEC61B, SEC61A1, SEC61G | S100B 2803/4885ALDH1A1 4817/4885MAPT 2487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.